Press Releases and Featured News

October 27, 2020 - Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment...read more

October 19, 2020 - CEOCFO Magazine Interview with Amytrx CEO About Advancing the Next Generation of Inflammation-Targeting Therapies: AMTX-100 Technology delivers First-in-Class Biologically Active Molecule to Treat Chronic Diseases Mediated by Inflammation...read more

October 8, 2020 - Amytrx Enrolling Clinical Trial of AMTX-100 in Patients with Atopic Dermatitis...read more

September 17, 2020 - Amytrx Therapeutics Emerges from Stealth to Develop Novel Therapies for Inflammatory Diseases with Lead Program AMTX-100 Currently in Clinical Development for Dermatologic Indications....read more


Amytrx Therapeutics, Inc.

102 Woodmont Blvd | Suite 243 Nashville, TN 37205

400 Riverhill Business Park | Suite 410 Birmingham, AL 35242

Copyright © 2020  All Rights Reserved.